Cytokines are potentially useful in vaccination as adjuvants or modulators of the type of response induced.
SL7207 was used as a carrier for two different high-level expression vectors. Both resulting strains, designated SL7207(pOmpAmIL-4) and SL7207(pKKmIL-4), expressed the cloned gene product as monitored by both immunological and biological assays. However, SL7207(pOmpAmIL-4) produced mIL-4 at higher levels and was more stable in vitro than SL7207(pKKmIL-4). When SL7207(pOmpAmIL-4) was used as a live vaccine in BALB/c mice, this strain grew and survived at higher levels than the parental attenuated strain or empty plasmid-carrying strain in spleens, livers, and intestines. This difference in growth and survival did not appear to be caused by alterations in specific lymphocyte-mediated anti-SalnoneUla immune responses such as delayed-type hypersensitivity or serum antibody as measured by enzyme-linked immunosorbent assay; such alterations have been induced by IL-4 administration in other in vivo systems, and the lack of effect here may reflect the fact that IL-4 is not secreted from the bacteria in large quantities, most of the cytokine being in the cytoplasmic-membrane-bound fraction. Conversely, the ability of mouse macrophages to kill the bacteria in vitro was inhibited by bacterial production of mIL-4. This reduction in macrophage killing activity suggests that bacterial production of mIL-4 may be detrimental to host defense against Salmonela infection and may explain the enhanced bacterial growth and survival in vivo.
Attenuated strains of Salmonella typhimurium recently have received much attention for their potential use as live vaccines against virulent Salmonella infections and also as live vaccine vectors carrying cloned genes of protective protein antigens of other pathogenic agents. Examples of the latter include various proteins from Escherichia coli (6, 11-13, 32, 44) , streptococcal M protein (54) , dengue virus envelope antigen (16) , Plasmodium sporozoite antigen (56) , a peptide of the I subunit of cholera toxin (51) , surface protein (gp63) of Leishmania major (62) , fragment C of tetanus toxin (20) , influenza A virus nucleoprotein (60) , and hepatitis B virus antigens (57) . Studies in animal models have demonstrated that immunization with these heterologous vaccines is an effective and safe way to induce both mucosal and serum antibodies against both Salmonella and foreign antigens. aroA mutants have a defect in aromatic amino acid synthesis caused by a deletion in the gene (30) . They are dependent on the mammalian host for these amino acids and also require para-aminobenzoic acid (PABA), which is not present in mammals. Thus, while the bacteria will colonize a mammalian host, their potential for growth is severely limited, particularly by their supplies of PABA. Their virulence is therefore greatly reduced; for example, * Corresponding author. the lethal dose for an intravenous (i.v.) injection into mice is lowered from a few organisms for the wild-type strain to the order of 105 to 106 (30) .
The immune system can respond to different types of bacterial, viral, and parasitic infections with a variety of effector mechanisms, which have varying degrees of effectiveness against each pathogen. For instance, while circulating antibodies may be effective against extracellular bacteria and act to neutralize exotoxins (21, 34) , some viruses will be eliminated only by a cytotoxic T-cell response (59) , whereas intracellular bacteria or parasites within phagocytes might require a response which would activate macrophages to kill the intracellular pathogen (33, 42, 43 In this report, we investigate the consequences of expressing the cytokine murine IL-4 (mIL-4) in an attenuated S. typhimurium strain subsequently introduced into normal BALB/c mice. Our interest in IL-4 derived primarily from observations that this cytokine is the only mediator to date capable of directing helper-T-cell precursors into a Th2 response in vitro (40, 58) and of skewing immune responses toward Th2 in vivo (9, 15). As mentioned above, Th2 cells are potent regulators of antibody production (50) and therefore may be the most desirable effector T cell to provide protective immunity against pathogens such as extracellular bacteria. Since Salmonella infection normally induces a Th1 response (62) , it provides a valuable system for exploring the Th switching capacity of IL-4 in vivo. Importantly, exhibits numerous other immunity-modulating properties both in vitro and in vivo, including the switching of antibody responses to immunoglobulin G subtype 1 (IgGl) and IgE isotypes (50) and the deactivation of macrophages (38, 41) . We examine here the consequence of mIL-4 expression by attenuated S. typhimurium on specific immune responses to these microorganisms. Our data indicate a significant local effect on macrophage function, which may explain enhanced in vivo growth of the bacteria, but no modification of systemic immunity. The latter probably reflects the lack of active secretion of mIL-4 by the bacteria under the conditions of this study.
MATERIALS AND METHODS
Mice. Six-week-old female B.ALB/c mice innately susceptible to Salmonella spp. were purchased from Simonsen Laboratories (Gilroy, Calif.). Purina Mouse Chow (Purina, St. Louis, Mo.) and fresh water were available ad libitum. All mice were acclimatized for at least 1 week before use.
Bacterial strains, plasmids, and media. S. typhimurium LB5000 (r-m+) has been described previously (7) . The attenuated strain SL7207, used throughout this study, was produced and generously provided by B. Stocker, Stanford University, Stanford, Calif. SL7207 was derived from the same virulent S. typhimurium ancestor as SL3261 (17, 30 (57) . SL7207 appears to be as nonvirulent as SL3261 and to be as effective as a live vaccine for the protection of BALB/c mice against virulent challenge (57a) .
All plasmids were maintained in E. coli K-12, using the host strain JM105 (63) or MM294 (4) . Plasmid pOmpAmIL-4 ( Fig. 1) (26) . pOmpAmIL-4 encodes a fusion protein which consists of a signal sequence (21 amino acids) from outer membrane protein (OMP) OmpA of E. coli (26) and the mature polypeptide sequence (120 amino acids) of mIL-4 (53). The signal sequence directs transport of the protein across the cytoplasmic membrane (26, 45) . Transcription of this fusion protein is driven by the constitutive lipoprotein promoter (lppP) of E. coli and the lac promoter and operator (lac"') (45) . Plasmid pKKmIL-4 was constructed from the expression vector pKK223-3 (Pharmacia, Piscataway, N.J.), which contains a strong tac promoter. pKK223-3 was digested with PstI (the PstI site was chosen because the cloned mIL-4 gene contains its own ribosome-binding site upstream of its ATG codon) and then blunt ended with DNA polymerase. The mIL-4 fragment and the vector pOmpA were isolated from an XbaI-BamHI digest of pOmpAmIL-4 ( Fig.  1) , and both fragments were gel purified and treated with DNA polymerase to create blunt ends. The empty vector was self-ligated to create the deletion construct known as pOmp. The blunt-ended vector pKK223-3 and mIL-4 insert were mixed and ligated. After transformation of E. coli MM294 by standard procedures (27) , ampicillin-resistant transformants were selected and digested with PstI and VOL. 61, 1993 on October 29, 2017 by guest http://iai.asm.org/
Downloaded from
HindIII to determine the correction orientation of the insert and then tested for production of mIL-4 by enzyme-linked immunosorbent assay (ELISA) (described below). One such ampicillin-resistant, mIL-4-producing isolate, designated pKKmIL-4, was selected for further study. All three plasmids, pOmpAmIL-4, pOmp, and pKKmIL-4, were retransformed into S. typhimurium SL7207 via the restriction modification strain LB5000 (r-m+), using published methods (3). Both SL7207 pOmpAmIL-4 and pKKmIL-4 were used in in vitro stability and expression analyses. Genetically manipulated strains were routinely tested for serologic characteristics with Salmonella anti-H and anti-O diagnostic sera (0-factor 4) purchased from Sigma Chemical Co., St. Louis, Mo. Enzymes for plasmid manipulations were purchased from New England BioLabs (Beverly, Mass.) and used as recommended by the manufacturer. Geneclean (Bio 101, Inc., La Jolla, Calif.) was used for DNA purification as outlined by the manufacturer.
All bacteria were cultured in L broth or on L-agar plates unless otherwise stated. Minimal medium consists of 2% Noble agar (Difco Laboratories, Detroit, Mich.) containing M9 salts, glucose, and Ca-Mg salts as described previously (52) . To grow aroA hisG strains on minimal medium, the medium was supplemented with the aromatic amino acids tryptophan, histidine, tryosine, and phenylalanine at a final concentration of 40 ,ug/ml each and 2,3-dihydroxy-benzoate, PABA, andpara-hydroxybenzoic acid at 10 pg/ml each (all supplements from Sigma).
Cytokines. Recombinant mIL-4 (E. coli) was kindly provided by W. Dang and S. Menon, DNAX. Recombinant mouse IFN--y was obtained from Schering Research, Bloomfield, N.J.; and recombinant mouse tumor necrosis factor alpha (TNF-a) was kindly provided by A. Zlotnik, DNAX.
Measurement of plasmid stability in vitro. Initially, plasmid-containing S. typhimurium cells were streaked onto L-agar plates containing 50 ,ug of ampicillin per ml from a frozen stock and grown overnight at 37°C. The next day, a single loopful of bacteria was resuspended in 5 ml of phosphate-buffered saline (PBS), and another 1 ,ul of each culture was inoculated into tubes containing S ml of L broth without antibiotic and regrown to stationary phase for 24 h. On the next day, 1 pl of each culture was used to inoculate the cultures for the following day, and the remaining L-broth culture was serially diluted 10'-fold in 10 ml of PBS without antibiotic, plated on nonselective medium, and scored 24 h later. The in vitro plasmid segregation from SL7207 was confirmed by transferring 100 colonies from nonselective medium to medium containing 50 ,ug of ampicillin per ml or no ampicillin; the culture was scored 24 h later to distinguish between plasmid-containing and plasmid-free S. typhimurium. This protocol was followed throughout the 10 days of the experiment. Each 24-h cycle represents approximately 14 generations of growth for a total of about 140 generations per strain. Assays were performed five times, with similar results.
Gene expression in S. typhimurium. While the construct pOmpAmIL-4 includes a copy of the lacI gene ( Fig. 1) , the lac operon is not present in the chromosome of S. typhimurium. Therefore, the production of mIL-4 by strains carrying the plasmid was tested in the presence or absence of the inducer IPTG (isopropylthio-3-D-galactosidase; Sigma). Cultures of M9 medium (10 ml containing 50 ,ug of ampicillin per ml supplemented with histidine and aromatic metabolites) were inoculated with SL7207(pOmpAmIL-4) (from an overnight culture) to a starting optical density of 0.05 (at 600 nm). At an optical density of 0.4, the cultures were induced by the addition of IPTG to a final concentration of 0.2 mM. After 2 more h of growth, cells were harvested by centrifugation. Periplasmic proteins were prepared by osmotic shock as described by Koshland and Botstein (37) . After osmotic shock, the remaining unfractionated pellet was saved as the cytoplasmic-membrane-bound fraction and resuspended in PBS-0.5% Triton X-100. All extracts were snap frozen and stored at -80°C. Constitutive gene expression of SL7207 (pOmpAmIL-4) and SL7207(pKKmIL-4) was Antigens. Lyophilized, phenol-water-extracted S. typhimurium lipopolysaccharide (LPS; Difco) was reconstituted with and diluted in distilled H20 at 10 mg/ml. Flagellar antigen from SL7207 was prepared as described before (22) at a final concentration of 1.6 mg/ml in PBS. Preparations of SL7207 OMPs were made as described previously (29) at a final concentration of 0.5 mg/ml in PBS. Whole-cell antigens were prepared as follows. Log-phase cells of SL7207 were harvested by centrifugation, washed in PBS and fixed in 2% formaldehyde, rewashed with PBS, centrifuged, resuspended in PBS at a final concentration of 2.5 x 1011 cells per ml, and then snap frozen.
Measurement of antibody response. To determine any possible effects of Salmonella mIL-4 expression on total antibody, or specific isotype responses to the bacteria, sera were obtained from 10 to 15 individual BALB/c mice by tail bleeding at 15, 30, and 60 days after i.v. infection with 3 x 106 CFU of the different strains. These sera were titrated by ELISA against the four different antigen preparations described above. ELISAs were performed as described above for the IL-4 ELISA, with plates being coated overnight with 2 x 108 killed cells per ml, or 5 p,g of LPS per ml, a 1/1,600 dilution of a purified flagellar preparation, or a 1/500 dilution of OMP. Following washing and blocking, serial dilutions of the mouse sera were added to the plates and the plates were incubated for 2 h at room temperature. Biotinylated antiimmunoglobulin conjugates wer_ all obtained from Pharminogen (San Diego, Calif.) and used at predetermined optimal concentrations in the assay. These included anti-mouse immunoglobulin and anti-IgGl, anti-IgG2a, anti-IgG2b, antiIgG3, anti-IgM, and anti-IgA. The anti-isotype antibodies used have been shown previously to be specific for the correct isotypes (31a). After a 1-h incubation with the biotin conjugates and washing, the plates were incubated with a streptavidin-horseradish peroxidase conjugate (Pierce Chemical, Rockford, Ill.) for 1 h at room temperature, and finally developed with ABTS substrate (Sigma). Titers were defined as the reciprocals of the serum dilution giving an optical density of 0.05 (18, 19) .
Determination of macrophage SabnoneUla-killing activity.
The ability of macrophages to kill mIL-4-expressing and nonexpressing strains was determined as described previously (35) . Resident peritoneal macrophages were harvested from normal BALB/c mice in RPMI (J.R.H. BioSciences, Lenexa, Kans.)-20% normal mouse serum. Monolayers of peritoneal macrophages were plated in triplicate in 24-well tissue culture plates at 106 cells per well and allowed to adhere for 3 h at 37°C. After 3 h, nonadherent cells were washed off and medium was replaced. Adherent cells were incubated overnight at 37°C with 1,000 U of IFN--y, 100 U of TNF-a, or 100 U of recombinant IL-4 (rIL-4) per ml.
Approximately 107 CFU of SL7207(pOmp) or SL7207(pOmp AmIL-4) bacteria were added in PBS-20% normal mouse serum, 0.5 ml per well. After 30 min, three SL7207(pOmp) and three SL7207(pOmpAmIL-4) wells, untreated, were washed several times with PBS to remove extracellular bacteria, lysed with 0.05% Triton X-100, and then plated to L-agar plates containing ampicillin (50 ,ug/ml) to provide a baseline number of CFU that had infected the macrophages. Cells were washed hourly to remove extracellular bacteria, and the remaining cells were washed well and lysed at 7 h. The percent killing was calculated as follows: 100-[(CFU after 7 h x 100)/CFU at baseline].
Statistics. All experiments were performed two to five times, and the significance of the differences observed was assessed by regression analysis, Mann-Whitney U test, or unpaired Student's t test, using the computer program StatView (Abacus Concepts, Berkeley, Calif.). Differences were considered significant when P values of <0.05 were obtained.
RESULTS
Stability and expression of two IL-4 gene-containing plasmids. In this experiment, the stability and level of in vitro expression of two plasmids (pOmpAmIL-4 and pKKmIL-4) which include the mIL-4 gene were examined. In the absence of antibiotic selection, the strain bearing the highcopy-number plasmid pKKmIL-4 showed significant plasmid loss, with more than 85% of the recovered isolates being ampicillin sensitive after approximately 14 generations (24 h), and was completely lost by the third subculture. In contrast, cells bearing pOmpAmIL-4 lost their plasmid more slowly. After approximately 140 generations (10 days), 22% of cells remained ampicillin resistant (data not shown). During each 24-h interval of the experiment, 10 selected ampicillin-resistant colonies were picked, and the level of in vitro mIL-4 produced was measured by ELISA. All tested ampicillin-resistant colonies throughout the 10 days of the experiment made mIL-4 (data not shown). These findings demonstrate that plasmid pOmpA is a more stable vector for the mIL-4 gene than plasmid pKK223-2 in the absence of antibiotic selection.
Expression of the mIL-4 gene was tested in strain SL7207(pOmpAmIL-4) under noninducing or inducing (presence of IPTG) conditions and under noninducing conditions for SL7207(pKKmIL-4). Three mIL-4 than SL7207(pKKmIL-4) in the pellet containing the cytoplasmic-membrane-bound fractions (>1,100 ng) and periplasmic factions (>10 ng). Supernatants of each culture were examined for the presence of mIL-4 in the growth medium; little to no secreted mIL-4 was detected for SL7207(pKKmIL-4) (<0.1 ng), whereas SL7207(pOmp AmIL-4) had higher levels (>10 ng). As expected, when SL7207(pOmpAmIL-4) was cultured under inducing conditions, it had significantly higher levels of mIL-4 in the culture medium (approximately 3-fold more [>7 ng]) and higher levels in both periplasmic and unfractionated cytoplasmicmembrane-bound fractions (approximately 10-fold more). However, this overproduction of protein appeared to become toxic to cells which were swollen and no longer rod shaped when viewed under a microscope.
In vitro biological assay on HT-2 cells indicated that the IL-4 produced and detected by ELISA was also biologically active, with approximately 10 ng of IL-4 obtained from the periplasmic fraction of 109 cells. On the basis of these results and the plasmid stability data presented above, only SL7207(pOmpAmIL-4) grown under noninducing conditions was studied further.
S. typhimurium strains expressing mIL-4 grow and persist at higher levels in vivo. Before we examined the effect of mIL-4 expression on specific immune responses to SL7207, it was important to evaluate the impact of this cytokine expression on bacterial growth and colonization. As shown in Fig. 2A and B, 24 h after i.v. administration of 3 x 106 bacteria, parental strain SL7207 was detectable at moderate levels in spleens and liver (103 to 104 bacteria per organ). In contrast, strain SL7207(pOmpAmIL-4) was detectable at higher levels (104 to 105 bacteria per organ) at the same sites, showing an average 10-to 50-fold increase in numbers compared with either parental strain SL7207 or SL7207 carrying plasmid pOmp, which lacks the mIL-4 gene ( Fig. 2A and B) , and the differences were statistically significant (P < 0.001) in both spleens and livers. Between days 1 and 10, the number of CFU of all three strains increased in both the spleens and livers but never exceeded the number inoculated. By day 5, pronounced splenomegaly was observed for all three strains tested. After day 10, the counts fell rapidly in both spleens and livers and were negative for all three strains tested in all mice by day 48 (data not shown). Similar results were obtained when bacterial counts in equivalent intestinal samples were compared, although more variability at this site was noted (Fig. 2C) . The differences between mIL-4-expressing and nonexpressing bacteria were more marked in the intestines than in liver and spleen.
One of the advantages of attenuated S. typhimunium as a vaccine vector is its suitability for oral administration. We therefore compared the effectiveness of IL-4-secreting SL7207 versus parental SL7207 upon oral administration to mice. Groups of BALB/c mice were given oral doses of 1010 parental SL7207 or strain SL7207(pOmpAmIL-4). Oral administration of these microorganisms led to very low levels of colonization of spleens and livers. Between days 1 and 5, both strains were detectable at low levels in both organs (<100 bacteria per organ). After day 5, the counts decreased rapidly, so that by days 14 and 21 both organs were clear of S. typhimurium (data not shown). However, by day 1 posttreatment, both strains were detectable in intestines at 102 to 103-5 per sample (Fig. 3) . In the SL7207(pOmpAmIL-4) group, the number of bacteria increased until day 10 to 103 CFU and then remained relatively constant at moderate levels (>3,000 CFU) through day 21 by the bacteria might affect T-helper-cell responses, DTH responses to killed S. typhimurium were assessed at 30 days post-i.v. infection with 3 x 106 CFU of SL7207(pOmpAmIL-4) or parental strain SL7207. The parental strain was used in these studies because its growth is closer to that of the mIL4 strain than is the growth of SL7207(pOmp), thus reducing the chance of simple differences in bacterial burden affecting immune responses. At 24 h after footpad injection of 106 CFU of heated-killed SL7207, the mean difference in thickness between injected and noninjected footpads was 2.33 mm (n = 15) for the mice given SL7207(pOmpAmIL-4) as live vaccine. For the mice vaccinated with parental strain SL7207, this difference was 2.02 mm (n = 15), whereas the mean swelling induced by a PBS injection was only 0.3 mm. Thus, both strains induced a DTH response, but there was no significant difference between the two groups. Similar results were obtained after 48 h.
Serum antibody responses to attenuated S. typhimurium are unaffected by mlI-4 expression. Serum samples from mice infected i.v. with 3 x 106 CFU of the parental strain or SL7207(pOmpAmIL4) were collected 15, 30, and 60 days postinfection and assayed for antibodies specific for several Salmonella antigens. There were no significant differences in the anti-Salmonella antibody responses observed in mice infected with either SL7207(pOmpAmIL-4) or SL7207 (Ta- (Tables 1 and 2 ).
SalmoneUla killing ability of macrophages is decreased by mIL-4 expression. As the expression of mIL-4 by S. typhimurium clearly led to increased numbers of live bacteria in spleens, livers, and intestines, without any detectable effect on cell-mediated or humoral immune responses to the bacteria, it was of interest to determine the possible mechanism behind the higher counts. Thus, the ability of BALB/c macrophages to kill S. typhimurium in vitro was assessed.
Macrophages from the peritonea of normal BALB/c mice were collected as described in Materials and Methods and then incubated with either SL7207(pOmp) or SL7207(pOmpAmIL4). Intracellular bacterial counts performed after a 7-h culture and compared with a baseline of 30 min indicated reduced killing of SL7207(pOmpAmIL4) in comparison to SL7207(pOmp) (Fig. 4) . This apparent protection from macrophage killing occurred even with the addition of the recombinant macrophage-activating cytokines IFN--y and TNF-a either alone or in combination (Fig. 4) . These data indicate that the expression of mIL-4 by S. typhimurinum is able to confer some protection against macrophage microbicidal activity. This effect was mimicked by the addition of exogenous rIL-4, which was able to reduce killing of SL7207(pOmp) to only 2% (P < 0.025), whereas killing of SL7207(pOmpAmIL-4) was unaffected by the addition of exogenous IL-4; i.e., it was 13% with or without exogenous IL-4.
DISCUSSION
The data presented here demonstrate that an attenuated aroA (deletion) strain of S. typhimunium, SL7207, is a useful vehicle for expression of the mIL-4 gene in vitro and in vivo. Initially, we compared the stability and levels of expression of mIL-4 in vitro with two different recombinant plasmids, each containing the gene for mIL-4 under a different promoter. Our data clearly indicate that both the stability of the plasmids and the levels of expression of the mIL-4 gene were quite different. In contrast to the plasmid-bearing strain SL7207(pOmpAmIL-4), which was clearly more stable throughout the 10 days of the experiment, the strain bearing pKKmIL-4 lost its plasmid very rapidly (>85%, within 24 h) in the absence of antibiotic selection and was completely lost after 30 generations. SL7207(pOmpAmIL-4) also produced more mIL-4 and was therefore selected for all subsequent work.
The effects of mIL-4 expression on bacterial colonization and persistence in vivo were then examined. Bacterial counts were assessed after i.v. and oral infection, with the striking finding that higher numbers of bacteria were obtained in the liver, spleen (i.v. route only), and intestine (both routes) following infection with the mIL-4-bearing strain than after infection with either the parental strain or the strain carrying the empty plasmid. While Thus, our findings suggest that intrinsic expression of mIL-4, while aiding bacterial growth or survival, had no apparent effect on specific anti-Salmonella immune responses. However, a possible explanation for this difference was revealed when we examined the ability of murine peritoneal macrophages to kill the SL7207(pOmpAmIL-4) and SL7207(pOmp) strains in vitro, when clear differences emerged. In every circumstance tested, macrophages were less able to kill the mIL-4-bearing strain than SL7207 (pOmp). This was true whether the cells were left without exogenous cytokines or were treated with the recombinant macrophage-activating cytokines IFN--y and TNF-a. This inhibition of killing was mimicked by the addition of rIL4 to the cultures, but interestingly, exogenous rIL4 did not affect the killing of the mIL4-bearing strain, perhaps because it was already maximally protected.
It may appear anomalous that the expression of mIL-4 by the bacteria is not affecting specific immunological responses that have been influenced by IL4 in other studies (9, 15, 40, 58) . It should be remembered, however, that the cytokine is not secreted by the bacteria; thus, one possible explanation is that mIL4 is only released in sufficient quantities on bacterial lysis and that the effect is either intracellular in the phagocyte, or very local, and insufficient quantities are available to affect lymphocytes. We are currently constructing a plasmid that will lead to secretion of the cytokine in the hope that greater effects on specific immune responses might be seen. Inhibition of macrophage killing by IL4 has been observed previously in several systems (38, 41) , and, in addition, in vivo administration of IL-4 to mice infected with L. monocytogenes resulted in increased bacterial growth (33) . This may be particularly relevant as there appear to be at least some common mechanisms of defense against Salmonella and Listeria spp., which both infect macrophages. In the first month or so of an aroA Salmonella infection, the host is cross-protected against Listeria spp., and this crossprotection is thought to be mediated by activated macrophages (52) . There are a large number of possible mechanisms by which IL4 might inhibit killing, and we are currently attempting to determine exactly which killing mechanisms are being inhibited. Experiments on macrophage killing indicated no difference in phagocytosis of the two strains (data not shown).
While the lack of any effect of IL4 on specific immune responses is slightly disappointing in relation to the potential of such vectors as live vaccines, it is quite possible that the large increase in intestinal colonization by the mIL-4-expressing strain might lead to more efficient mucosal immunization, and we are currently in the process of examining the effects of vaccination with these strains on protection against oral challenge with a virulent strain, SL1344, and on the mucosal IgA response. If the mIL-4 strain is markedly better in either of these two assays, it could be of great potential benefit in vaccination. It is also important to determine why the increase in colonization of intestines is so large in relation to other tissues. Further analysis of bacterial growth in the intestines, which would distinguish among bacteria in the lumen, the intestinal circulation, lamina propria, or Peyer's patches, is currently under way.
In addition to bacterial killing, macrophages are also able to have a suppressive effect in Salmonella infection (2, 39) . Following infection with aroA strains, there is suppression of both antibody responses to injected antigens and in vitro responses of spleen cells to B-and T-cell mitogens (2) . The suppression of in vitro mitogen and other responses can be reversed by IL-4 (1), and thus it will be interesting to see whether infection with the mIL-4-carrying Salmonella strain will lead to lower immunosuppression, which would probably be desirable. These studies are currently under way.
Liew and coworkers recently have described the use of S. typhimurium to express human IL-lp in vivo (8) . Mice infected with these bacteria produced a significant antibody response against the cytokine and were better protected against lethal gamma irradiation. The authors emphasized the point that expression of therapeutic cytokines by S. typhimurium might be an effective method of delivery directly to the lymphoid organs; thus, the usefulness of such expression vectors might not be limited to vaccination. This is also true of bacteria expressing mIL4, and since mIL-4 has been shown to protect against septic shock (unpublished observation), which is presumably due to an effect on the macrophage, we are currently assessing the effect of infection with these bacteria on their resistance to LPS-mediated stock.
Cytokines expressed by S. typhimunum can clearly have biological effects in the host, and we are currently examining different constructs designed to express other cytokines and cytokine combinations.
